- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06120231
Pulse-Width Modulation
July 7, 2026 updated by: Linton T. Evans, Dartmouth-Hitchcock Medical Center
Pulse-width Modulation During Pedicle Screw Stimulation
The overarching aim of this project is to modulate the pulse-width during stimulation of pedicle screws and record the response thresholds associated with each PWM setting.
During this initial phase of the investigation, no further data will be collected.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
In vivo electrical stimulation of pedicle screws is a well-documented modality for evaluating potential breach of the pedicle wall.
However, previous research has focused primarily on the stimulation threshold intensity required to elicit a neurophysiological response.
Other stimulation parameters, such as pulse-width, remain uninvestigated.
The goal is to obtain data on the pulse-width vs. CMAP relationship.
Study Type
Interventional
Enrollment (Estimated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lauren Sinks, MPH
- Phone Number: 6036179909
- Email: Lauren.J.Sinks@hitchcock.org
Study Locations
-
-
New Hampshire
-
Lebanon, New Hampshire, United States, 03677
- Recruiting
- Dartmouth-Health
-
Contact:
- Beverly Allen, BS
- Phone Number: 603-653-9021
- Email: Beverly.A.Allen@hitchcock.org
-
Principal Investigator:
- Linton Evans, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- A patient will be eligible for study participation once they have been booked for a surgery involving pedicle screw placement and intraoperative neuromonitoring.
Exclusion Criteria:
- The study excludes neonates, minors, pregnant women, prisoners and cognitively impaired patients.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Pedicle Screw Stimulation Arm
|
Will be stimulating the pedicle screws utilizing three different pulse-width settings, 0.4 milliseconds, 0.2 milliseconds, and 0.05 milliseconds.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
CMAP response under three different pulse-width settings
Time Frame: Within operating room upon completion of pedicle screw placement. 1 day
|
Upon completion of the pedicle screw placements, each screw will be stimulated utilizing three different pulse-width settings, 0.4 milliseconds, 0.2 milliseconds, and 0.05 milliseconds.
The stimulation intensity required to elicit a compound muscle action potential (CMAP) will be recorded for each pulse-width parameter.
This is measured in microvolts (uV).
|
Within operating room upon completion of pedicle screw placement. 1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Linton Evans, Dr., Dartmouth-Hitchcock Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2023
Primary Completion (Actual)
June 1, 2026
Study Completion (Estimated)
October 1, 2027
Study Registration Dates
First Submitted
November 1, 2023
First Submitted That Met QC Criteria
November 1, 2023
First Posted (Actual)
November 7, 2023
Study Record Updates
Last Update Posted (Actual)
July 9, 2026
Last Update Submitted That Met QC Criteria
July 7, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY02001964
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.